Prolonged Hypoxic Exposure Impairs Endothelial Functions: Possible Mechanism of HIF-1α Signaling
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
PURPOSE: Hypoxic training enhances oxygen availability by elevating hemoglobin, red blood cells, and capillaries. hypoxia-inducible factor (HIF) stabilization under hypoxic conditions triggers glycolysis, erythropoiesis, and angiogenesis. However, prolonged hypoxic exposure causes endothelial cell dysfunction, contributing to cardiovascular diseases. Furthermore, endothelial mitochondria play a crucial role in maintaining endothelial cell homeostasis through the processes of biogenesis, signaling cellular response, mitochondrial dynamics, and calcium homeostasis. However, the molecular response of endothelial mitochondria has not been fully elucidated. Therefore, this study aimed to investigate the endothelial mitochondria functions and morphological change in response to hypoxia. METHODS: Cobalt chloride and 2% hypoxic condition were applied to HUVECs. The endothelial cell functions were assessed using BrdU-based proliferation assay and scratch wound healing assays. Mitochondrial functions were evaluated using Mitosox and MitoTracker staining for mitochondrial reactive oxygen species (mtROS) and mitochondrial morphology analysis, respectively. RESULTS: The hypoxic condition (2% of O2) significantly decreased endothelial proliferation/migration and mitochondrial function. Furthermore, CoCl2 treatment increased the mtROS levels and mitochondrial fragmentation in HUVECs. Additionally, hypoxic conditions were found to regulate the phosphorylation of eNOS, mitochondrial biogenesis, mitophagy, and cell cycle-related protein expression. CONCLUSIONS: These results suggest that the HIF-α pathway leads to endothelial dysfunction via mitochondrial dysfunction. Further mechanistic studies will be needed to elucidate the cellular and molecular mechanisms by which hypoxic-response pathways influence the health and homeostasis of endothelial cells. The findings reported herein underscore the importance of strategies for hypoxic training to prevent cardiovascular diseases
Abstract
PURPOSE: Hypoxic training enhances oxygen availability by elevating hemoglobin, red blood cells, and capillaries. hypoxia-inducible factor (HIF) stabilization under hypoxic conditions triggers glycolysis, erythropoiesis, and angiogenesis. However, prolonged hypoxic exposure causes endothelial cell dysfunction, contributing to cardiovascular diseases. Furthermore, endothelial mitochondria play a crucial role in maintaining endothelial cell homeostasis through the processes of biogenesis, signaling cellular response, mitochondrial dynamics, and calcium homeostasis. However, the molecular response of endothelial mitochondria has not been fully elucidated. Therefore, this study aimed to investigate the endothelial mitochondria functions and morphological change in response to hypoxia. METHODS: Cobalt chloride and 2% hypoxic condition were applied to HUVECs. The endothelial cell functions were assessed using BrdU-based proliferation assay and scratch wound healing assays. Mitochondrial functions were evaluated using Mitosox and MitoTracker staining for mitochondrial reactive oxygen species (mtROS) and mitochondrial morphology analysis, respectively. RESULTS: The hypoxic condition (2% of O2) significantly decreased endothelial proliferation/migration and mitochondrial function. Furthermore, CoCl2 treatment increased the mtROS levels and mitochondrial fragmentation in HUVECs. Additionally, hypoxic conditions were found to regulate the phosphorylation of eNOS, mitochondrial biogenesis, mitophagy, and cell cycle-related protein expression. CONCLUSIONS: These results suggest that the HIF-α pathway leads to endothelial dysfunction via mitochondrial dysfunction. Further mechanistic studies will be needed to elucidate the cellular and molecular mechanisms by which hypoxic-response pathways influence the health and homeostasis of endothelial cells. The findings reported herein underscore the importance of strategies for hypoxic training to prevent cardiovascular diseases
참고문헌 (33)
- Karuppagounder SS, "Hypoxia-inducible factor prolyl hydroxylase inhibition : robust new target or another big bust for stroke therapeutics?", J Cereb Blood Flow Metab, 32(7), pp.1347~1361 (2012)
- Majmundar AJ, "Hypoxia-inducible factors and the response to hypoxic stress", Mol Cell, 40(2), pp.294~309 (2010)
- Hong SG, "Flow patterndependent mitochondrial dynamics regulates the metabolic profile and inflammatory state of endothelial cells", JCI Insight, 7(18) (2022)
- Zimna A, "Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis : applications and therapies", Biomed Res Int, 2015, pp.549412~ (2015)
- Semenza GL, "Hypoxia-inducible factor 1 : master regulator of O2 homeostasis", Curr Opin Genet Dev, 8(5), pp.588~594 (1998)
- Gore CJ, "Altitude training and haemoglobin mass from the optimised carbon monoxide rebreathing method determined by a meta-analysis", Br J Sports Med, 47, pp.31~39 (2013)
- Nunomiya A, "Activation of the hypoxia-inducible factor pathway induced by prolyl hydroxylase domain 2 deficiency enhances the effect of running training in mice", Acta Physiol(Oxf), 220(1), pp.99~112 (2017)
- Shin J, "Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin", NFATc1-dependent pathway, 2016, pp.6, 5~
- Martin NRW, "Hypoxia impairs muscle function and reduces myotube size in tissue engineered skeletal muscle", J Cell Biochem, 118(9), pp.2599~2605 (2017)
- Abe H, "The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases", J Atheroscler Thromb, 24(9), pp.884~894 (2017)
- Bosc LV, "Mechanisms of intermittent hypoxia induced hypertension", J Cell Mol Med, 14, pp.3~17 (2010)
- Hulten LM, "The role of hypoxia in atherosclerosis", Curr Opin Lipidol, 20(5), pp.409~414 (2009)
- Di Mattia M, "Hypoxia-mimetic CoCl(2) agent enhances pro-Angiogenic activities in ovine amniotic epithelial cells-derived conditioned medium", Cells, 11(3) (2022)
- Janaszak-Jasiecka A, "Endothelial dysfunction driven by hypoxia-the influence of oxygen deficiency on NO bioavailability", Biomolecules, 11(7) (2021)
- Bartoszewski R, "Primary endothelial cell-specific regulation of hypoxia-inducible factor(HIF)-1 and HIF-2 and their target gene expression profiles during hypoxia", FASEB J, 33(7), pp.7929~7941 (2019)
- Qian L, "Hypoxic adipose stem cell-derived exosomes carrying high-abundant USP22 facilitate cutaneous wound healing through stabilizing HIF-1alpha and upregulating lncRNA H19", FASEB J, 38(10), pp.e23653~ (2024)
- Kim B, "Inhibition of drp1-dependent mitochondrial division impairs myogenic differentiation", Am J Physiol Regul Integr Comp Physiol, 305(8), pp.927~938 (2013)
- Hong Z, "Role of dynamin-related protein 1(Drp1)-mediated mitochondrial fission in oxygen sensing and constriction of the ductus arteriosus", Circ Res, 112(5), pp.802~815 (2013)
- Koopman WJ, "Inhibition of complex I of the electron transport chain causes O2-.-. mediated mitochondrial outgrowth", Am J Physiol Cell Physiol, 288(6), pp.1440~1450 (2005)
- Yang C, "N-Acetylcysteine protects against cobalt chloride-induced endothelial dysfunction by enhancing glucose-6-phosphate dehydrogenase activity", FEBS Open Bio, 12(8), pp.1475~1488 (2022)
- Wang S, "Ablation of endothelial prolyl hydroxylase domain protein-2 promotes renal vascular remodelling and fibrosis in mice", J Cell Mol Med, 21(9), pp.1967~1978 (2017)
- Wang S, "Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling", Oncotarget, 7(37), pp.58848~58861 (2016)
- Murphy MP, "How mitochondria produce reactive oxygen species", Biochem J, 417(1), pp.1~13 (2009)
- Kluge MA, "Mitochondria and endothelial function", Circ Res, 112(8), pp.1171~1188 (2013)
- Flippo KH, "AKAP1 protects from cerebral ischemic stroke by inhibiting drp1-dependent mitochondrial fission", J Neurosci, 38(38), pp.8233~8242 (2018)
- Kim H, "Finetuning of Drp1", Fis1 availability by AKAP121, Mol Cell, pp.2011, 44(4)[DOI]
- Kuo CW, "mtDNA as a mediator for expression of hypoxia-inducible factor 1alpha and ROS in hypoxic neuroblastoma cells", Int J Mol Sci, 18(6) (2017)
- Chen X, "Hypoxia promotes pulmonary vascular remodeling via HIF-1alpha to regulate mitochondrial dynamics", J Geriatr Cardiol, 16(12), pp.855~871 (2019)
- Hart PC, "MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer", Nat Commun, 6, pp.6053~ (2015)
- Diebold LP, "Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis", Nat Metab, 1(1), pp.158~171 (2019)
- Huang Q, "TFAM loss induces nuclear actin assembly upon mDia2 malonylation to promote liver cancer metastasis", EMBO J, 41(11), pp.e110324~ (2022)
- Koh JH, "Mitochondrial TFAM as a signaling regulator between cellular organelles : a perspective on metabolic diseases", Diabetes Metab J, 45(6), pp.853~865 (2021)
- Murohara T, "Role of endothelial nitric oxide synthase in endothelial cell migration", Arterioscler Thromb Vasc Biol, 19(5), pp.1156~1161 (1999)